We are live on ! Find out more
IRD

Opus Genetics
IRD

48 hedge funds and large institutions have $32.1M invested in Opus Genetics in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 4

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

95% more capital invested

Capital invested by funds: $16.5M → $32.1M (+$15.6M)

12% more funds holding

Funds holding: 43 → 48 (+5)

2.44% more ownership

Funds ownership: 29.34% → 31.78% (+2.4%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
48
Holders Change
+5
Holders Change %
+11.63%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
10
Increased
12
Reduced
4
Closed
4
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$19K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.19M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$435K
3
Creative Planning
Creative Planning
Kansas
+$159K
4
Citadel Advisors
Citadel Advisors
Florida
+$141K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$141K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$158K
2
OM
Opaleye Management
Massachusetts
-$149K
3
Millennium Management
Millennium Management
New York
-$120K
4
VF
Virtu Financial
New York
-$75K
5
UBS Group
UBS Group
Switzerland
-$33.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Raymond James Financial
26
Raymond James Financial
Florida
$37.1K +$13.7K +11,000 +96%
HF
27
HRT Financial
New York
$34K +$25.7K +20,677 New
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$33.4K +$3.62K +2,910 +17%
KPWS
29
Kestra Private Wealth Services
Texas
$31.4K – – –
TSS
30
Two Sigma Securities
New York
$29.3K +$22K +17,746 New
JIR
31
James Investment Research
Ohio
$27K – – –
NA
32
NewEdge Advisors
Louisiana
$27K – – –
BFC
33
Bedel Financial Consulting
Indiana
$24.8K – – –
Osaic Holdings
34
Osaic Holdings
Arizona
$23.7K +$5 +4 +0%
Prudential Financial
35
Prudential Financial
New Jersey
$21.6K +$16.3K +13,100 New
SFO
36
Stokes Family Office
Louisiana
$20K – – –
Comerica Bank
37
Comerica Bank
Texas
$19.8K – – –
RIP
38
Reliant Investment Partners
North Carolina
$18.8K – – –
Two Sigma Advisers
39
Two Sigma Advisers
New York
$16.8K +$12.7K +10,200 New
Wells Fargo
40
Wells Fargo
California
$6.25K – – –
SS
41
SBI Securities
Japan
$4.26K -$1.24K -1,000 -28%
National Bank of Canada
42
National Bank of Canada
Quebec, Canada
$3.3K – – –
Barclays
43
Barclays
United Kingdom
$3.13K – – –
UBS Group
44
UBS Group
Switzerland
$1.46K -$33.8K -27,226 -97%
Bank of America
45
Bank of America
North Carolina
$632 +$122 +98 +34%
MCM
46
MAI Capital Management
Ohio
$203 – – –
Citigroup
47
Citigroup
New York
$2 +$1 +1 New
Millennium Management
48
Millennium Management
New York
– -$120K -127,844 Closed
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
– -$158K -127,220 -100%
VF
50
Virtu Financial
New York
– -$75K -79,346 Closed
1
2
3

IRD Hedge Fund Activity: Q3 2025 in Review

48 of the 7,626 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q3 2025, worth a combined $32.1M — up 95% from $16.5M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new IRD positions and 4 closed out — a net gain of 6 holders — while 12 added to existing stakes and 4 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $1.19M. The largest seller was Royal Bank of Canada, cutting an estimated $158K.

  • 48 institutional investors held Opus Genetics (IRD) as of Q3 2025, up from 43 in Q2 2025.
  • Funds reported $32.1M of Opus Genetics stock for Q3 2025, up 95% quarter-over-quarter.
  • 10 funds opened new Opus Genetics positions in Q3 2025 and 4 closed out, a net change of +6 holders.
  • The largest Opus Genetics buyer in Q3 2025 was Adage Capital Partners, an estimated $1.19M added.
  • The largest Opus Genetics seller in Q3 2025 was Royal Bank of Canada, an estimated $158K sold.

Based on aggregated 13F filings for Q3 2025.